Jing Chen
Huashan Hospital · University of Texas · University of Texas Southwestern Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jing Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:39 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07882017 · Tenapanor in Maintenance Hemodialysis PatientsHuashan Hospital · not yet recruiting · Hyperphosphatemia, Maintenance Hemodialysis · principal investigator
- N/ANCT07769190 · Cardiovascular Mortality Prediction in Maintenance Hemodialysis PatientsHuashan Hospital · completed · End-Stage Kidney Disease (ESKD), Cardiovascular Disease, Secondary Hyperparathyroidism (SHPT) · principal investigator
- N/ANCT07765134 · Comprehensive Kidney Function Assessment and Early Warning in Older AdultsHuashan Hospital · completed · Kidney Function Decline, Chronic Kidney Disease, Kidney Failure · principal investigator
- N/ANCT07741279 · Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD PatientsHuashan Hospital · recruiting · Anemia of Chronic Kidney Disease, CKD, Non-dialysis Chronic Kidney Disease · principal investigator
- Ph2NCT07654231 · REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label TrialUniversity of Texas Southwestern Medical Center · not yet recruiting · Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function, Vascular Calcification · principal investigator
- N/ANCT07466329 · Research and Validation of a Big Data-Driven Intelligent Decision-Making System for HemodialysisHuashan Hospital · completed · ESRD (End Stage Renal Disease) · principal investigator
- N/ANCT07368946 · Phosphate Assessment in Chronic Kidney Disease Patients StudyUniversity of Texas Southwestern Medical Center · recruiting · Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder · principal investigator
- N/ANCT07361783 · Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 TrialChen Jing · recruiting · Primary PCI, ST-elevation Myocardial Infarction (STEMI) · principal investigator
- N/ANCT07245186 · Strategies for Proactive Health in People With Kidney Function DeclineHuashan Hospital · enrolling by invitation · Renal Insufficiency,Chronic, Dietary Intake Patterns, Malnutrition · principal investigator
- N/ANCT06775067 · Incremental Dialysis Decision Model Based on Expert-Guided Machine LearningHuashan Hospital · completed · End-stage Renal Disease · principal investigator
- N/ANCT06765811 · Rapid Kidney Function Decline in Older AdultsHuashan Hospital · completed · Kidney Function Decline, Glomerular Filtration Rate, Urine Albumin-creatinine Ratio · principal investigator
- N/ANCT06423131 · Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCTSijia Gu · recruiting · Graft-Versus-Host Disease, Hematopoietic Stem Cell Transplantation, Child, Only · principal investigator
- Ph2NCT06367075 · A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue SarcomaUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · recruiting · Advanced Soft-tissue Sarcoma · principal investigator
- Ph3NCT06329622 · Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney DiseaseHuashan Hospital · recruiting · Chronic Kidney Disease, Sarcopenia · principal investigator
- Ph1/Ph2NCT05867420 · A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.AskGene Pharma, Inc. · recruiting · Advanced Solid Tumors · study director
- Ph1NCT05798546 · Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)BGI, China · unknown · Solid Tumor · principal investigator
- N/ANCT05329155 · Early Administration of Heparin At FMC for PPCI of STEMI PatientsRenmin Hospital of Wuhan University · completed · STEMI, Primary PCI · principal investigator
- Ph2NCT04910126 · Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue SarcomaUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · unknown · Soft Tissue Sarcoma, Neoplasms, Connective and Soft Tissue, Sarcoma Metastatic · study chair
- N/ANCT04433455 · Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis PatientsHuashan Hospital · recruiting · Hemodialysis, Cognitive Impairment, Cerebrovascular Disorders · principal investigator
- N/ANCT04033627 · TCDαβ/CD45RA Haploidentical Transplantation in Children With LeukemiaShanghai Children's Medical Center · unknown · Relapsed Pediatric ALL, Acute Graft-Versus-Host Disease (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML · principal investigator
- Ph2NCT03321123 · MB-CART19.1 in Patients With R/R ALLShanghai Children's Medical Center · unknown · Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory · principal investigator
- Ph4NCT03123406 · Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTKyowa Kirin China Pharmaceutical Co., Ltd. · completed · Hyperparathyroidism; Secondary, Renal · principal investigator
- Ph2NCT02552888 · Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) TrialTulane University · completed · Chronic Kidney Disease · principal investigator
- Ph4NCT01820832 · Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKDHuashan Hospital · unknown · Chronic Kidney Disease, Proteinuria · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 34 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical Research and Community Engagement CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · fiscal years 2016 to 2026 · $252,123 awarded in 2026Same name and institution; not confirmed by an ID
- Molecular control of age-related retinal synaptic remodelingR01EY031765 · NEI · BOSTON CHILDREN'S HOSPITAL · fiscal years 2020 to 2026 · $598,217 awarded in 2026Same name and institution; not confirmed by an ID
- RORalpha mediates chronic subretinal inflammation associated with AMDR01EY024963 · NEI · BOSTON CHILDREN'S HOSPITAL · fiscal years 2015 to 2025 · $507,705 awarded in 2025Same name and institution; not confirmed by an ID
- Tulane Clinical Center for Chronic Renal Insufficiency Cohort StudyU01DK060963 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · fiscal years 2020 to 2025 · $261,556 awarded in 2025Same name and institution; not confirmed by an ID
- Establishing A New Diagnostic Paradigm for Peripheral Artery Disease among Patients with Chronic Kidney DiseaseR01HL157903 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · fiscal years 2021 to 2023 · $13,116 awarded in 2023Same name and institution; not confirmed by an ID
- Wnt signaling-mediated control of blood-retinal barrierR01EY028100 · NEI · BOSTON CHILDREN'S HOSPITAL · fiscal years 2017 to 2021 · $429,225 awarded in 2021Same name and institution; not confirmed by an ID
- Urinary Angiotensinogen Excretion and Salt-Sensitivity of Blood PressureR01HL116898 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · fiscal years 2014 to 2016 · $697,264 awarded in 2016Same name and institution; not confirmed by an ID
- ENDOTHELIAL DYSFUNCTION, ADIPOCYTOKINES, INFLAMATION AND CHRONIC KIDNEY DISEASEP20RR017659 · NCRR · TULANE UNIVERSITY OF LOUISIANA · fiscal years 2008 to 2011 · $213,891 awarded in 2011Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Louisiana Clinical and Translational Science CenterU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · fiscal years 2012 to 2026Named on NCT02552888
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:39 UTC. The ranking covers the 200 most relevant of 3759 PubMed records, and a shared surname and initials can bring in a namesake. All 3759 on PubMed
- Large Language Model Influence on Diagnostic Reasoning: A Randomized Clinical Trial.JAMA Netw Open · 2024502 citationsRCR 94.5
- Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.N Engl J Med · 2025391 citationsRCR 108.0
- Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma.N Engl J Med · 2024220 citationsRCR 62.0
- 163 citationsRCR 28.4
- Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nat Med · 2024145 citationsRCR 14.6
- 139 citationsRCR 23.0
- GPT-4 assistance for improvement of physician performance on patient care tasks: a randomized controlled trial.Nat Med · 2025136 citationsRCR 37.4
- 116 citationsRCR 29.0
- 107 citationsRCR 19.0
- 82 citationsRCR 27.2